TIM
KZR

Tortoise Investment Management’s Kezar Life Sciences KZR Stock Holding History

Tortoise Investment Management’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-55
Closed -$4K – 619
2019
Q2 		$4K Buy
55
+18
+49% +$2.8K ﹤0.01% 513
2019
Q1 		$6K Buy
37
+19
+106% +$3.75K ﹤0.01% 469
2018
Q4 		$4K Buy
+18
New +$4.4K ﹤0.01% 466

Other funds holding KZR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Tortoise Investment Management's KZR Position: Q3 2019 in Review

Tortoise Investment Management sold out of Kezar Life Sciences (KZR) in Q3 2019, closing a stake of 55 shares — an estimated $4K sold.

Tortoise Investment Management first reported a position in KZR in Q4 2018 and held it in 3 quarters. The position peaked at $6K in Q1 2019. 54 funds tracked by Wall St. Rank hold KZR as of Q3 2019.

  • Tortoise Investment Management reported no remaining Kezar Life Sciences position as of Q3 2019 after selling out during the quarter.
  • Tortoise Investment Management sold 55 Kezar Life Sciences shares in Q3 2019, an estimated $4K.
  • Tortoise Investment Management first reported a position in Kezar Life Sciences in Q4 2018 and held it in 3 quarters.
  • Tortoise Investment Management's Kezar Life Sciences position peaked at $6K in Q1 2019.
  • 54 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q3 2019.

Based on Tortoise Investment Management's 13F filing for Q3 2019, filed 6 Nov 2019.